# Intelligent Bio (INBS) — Earnings

INBS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/inbs/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$3.60 |
| EPS estimate | −$1.20 |
| EPS surprise | −200.00% |
| Revenue surprise | −80.37% |
| Revenue | $843,884.00 |
| Revenue estimate | $4.3M |
| Reported | Aug 15, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1725430/000149315225012101/form8-k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2025 | Aug 15, 2025 | −$1.20 | −$3.60 | -200.00% | $4.3M | $843,884.00 |
| Q3 2025 | May 13, 2025 | −$2.80 | −$4.40 | -57.14% | $3.3M | $728,867.00 |
| Q2 2025 | Feb 13, 2025 | −$3.20 | −$5.00 | -56.25% | $2.3M | $607,494.00 |
| Q1 2025 | Nov 7, 2024 | −$5.30 | −$7.00 | -32.08% | $1.8M | $872,287.00 |
| Q4 2024 | Sep 9, 2024 | −$5.10 | $96.00 | 1982.35% | $1.4M | $730,000.00 |
| Q3 2024 | May 8, 2024 | −$8.70 | −$14.30 | -64.37% | $1.2M | $823,800.00 |
| Q2 2024 | Feb 9, 2024 | −$32.40 | −$20.70 | 36.11% | $1.0M | $764,063.00 |
| Q1 2024 | Nov 8, 2023 | −$76.80 | −$124.80 | -62.50% | $1.0M | $796,094.00 |
| Q3 2023 | May 11, 2023 | −$324.00 | −$686.40 | -111.85% | $420,000.00 | $457,058.00 |
| Q2 2023 | Feb 14, 2023 | −$264.00 | −$55.20 | 79.09% | $700,000.00 | $356,679.00 |
| Q1 2023 | Nov 9, 2022 | −$240.00 | −$192.00 | 20.00% | — | $311,320.00 |
| Q4 2022 | Aug 31, 2022 | −$168.00 | −$360.00 | -114.29% | $1.6M | — |
| Q3 2022 | May 11, 2022 | −$648.00 | −$216.00 | 66.67% | — | $192,500.00 |
| Q2 2022 | Feb 10, 2022 | −$552.00 | −$552.00 | 0.00% | $300,000.00 | $177,791.00 |
| Q1 2022 | Nov 11, 2021 | $0.00 | −$240.00 | 0.00% | — | — |

## Frequently Asked Questions

### When did Intelligent Bio (INBS) last report earnings?

Intelligent Bio last reported on Aug 15, 2025, covering fiscal Q4 2025.

### Did INBS beat earnings estimates?

No. Intelligent Bio reported EPS of −$3.60 for Q4 2025 against a −$1.20 estimate — a 200.00% miss.

### How much revenue did INBS report last quarter?

Intelligent Bio reported $843,884.00 in revenue for Q4 2025, against a consensus estimate of $4.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).